PROWESS-SHOCK
2012 Sepsis
? ICUs
1697 patients
Xigris for septic shock - robust trial design. DrotAA removed from market
Clinical Question
Loading...
Critical Appraisal
Key findings
No diff 28d & 90d mort., incl subgroups. More non-serious bleeding
- Population
- Sepsis
- Population Details
- Not recorded
- Intervention Arms
-
Activated Protein C
- Control Arms
- Not recorded
- Primary Outcome
- Not recorded
- Secondary Outcomes
- Not recorded
- P Value
- Not recorded
Outcome Results
Not recorded
Primary location: Worldwide